Publications by authors named "K J Flynn"

An open reading frame from the actinobacterium Mycolicibacterium smegmatis annotated as a Prostaglandin H Synthase (PGHS) was expressed with an N-terminal (his) tag and purified to homogeneity. The enzyme has a monomeric molecular weight of 68.3 kD and exists as a dimer in the presence of nonionic detergent.

View Article and Find Full Text PDF

Objective: Evaluate the effect of fathers' participation in the Preemie Prep for Parents (P3) program on maternal learning and fathers' preterm birth knowledge.

Methods: Mothers with preterm birth predisposing medical condition(s) enrolled with or without the baby's father and were randomized to the P3 intervention (text-messages linking to animated videos) or control (patient education webpages). Parent Prematurity Knowledge Questionnaire assessed knowledge, including unmarried fathers' legal neonatal decision-making ability.

View Article and Find Full Text PDF
Article Synopsis
  • Geostatistical data on drug overdose mortality is often aggregated at larger geographic levels, which can mask significant disparities in urban areas.
  • This study focused on Cuyahoga County, Ohio, analyzing drug-related mortality rates at the finer census tract level, revealing that individuals in low-opportunity areas are four times more likely to experience drug-related deaths compared to those in high-opportunity areas.
  • The research emphasizes the importance of detailed geographic analysis to uncover variations in drug mortality risk, suggesting that targeting specific communities can enhance public health interventions.
View Article and Find Full Text PDF

Introduction: Insulin-like growth factor binding protein-3 (IGFBP-3) exerts varying effects on estrogen receptor alpha (ERα)-positive and triple-negative breast cancer (TNBC) cells. In ERα-positive cells, IGFBP-3 is antiproliferative and proapoptotic. In contrast, IGFBP-3 stimulates proliferation in triple-negative breast cancer (TNBC) cells via EGFR activation.

View Article and Find Full Text PDF

Purpose: Few risk factors for early adjuvant endocrine discontinuation have been identified, but clinical trials suggest pre-AET symptom burden might be important. We sought to assess this in an academic practice.

Methods: We examined baseline and up to five years of follow-up information for postmenopausal women with stage I-III hormone-receptor positive breast cancer 2014-2019 receiving oncologist prescriptions for AET.

View Article and Find Full Text PDF